Literature DB >> 19473706

Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals.

Kathleen A Brady1, Mark Weiner, Barbara J Turner.   

Abstract

The inpatient medical service may be an important location to identify undiagnosed hepatitis C virus (HCV) infection. We conducted a cross-sectional HCV prevalence study in consecutive patients aged 18-65 admitted in a three-month period to two urban hospitals' general internal medicine and trauma services. Patient sera were anonymously screened for anti-HCV antibody with an enzyme-linked immunoassay and, when anti-HCV positive (+), for HIV. Health system records were examined for prior HCV testing or diagnosis or an HIV diagnosis then linked anonymously to test results. Multivariate logistic regression was used to examine associations of patient and health care factors with unknown HCV+ status. Of 786 unique patients tested (60.3% of all admitted patients), 62 (7.9%) were HCV+ without a prior HCV+ test or diagnosis while 61 patients (7.8%) tested HCV+ but had prior HCV+ test or diagnosis. Of 62 patients with unknown HCV+, 6 (9.7%) were HIV+ but only 3 had a prior HIV diagnosis; of 61 patients with known HCV+, all 9 (14.8%) HIV+ had been diagnosed. Among the 640 patients with prior unknown HCV status, an HCV+ test was strongly associated with age: 50-65 (adjusted odds ratio [AOR] 5.44, CI 2.20-13.48) and age 36-49 (AOR 4.65, CI 1.91-11.32) versus. 18-35. In this anonymous study, we could not obtain HCV risk factor data but the positive and negative predictive values of HCV testing all inpatients with an unknown HCV status were 99.3% and 99.0%, respectively. In similar urban general medicine and trauma services, broader efforts to test for HCV in inpatients aged 36-65 may be warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19473706      PMCID: PMC4020138          DOI: 10.1016/j.jinf.2009.04.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  38 in total

1.  Racial differences in knowledge regarding hepatitis C virus infection.

Authors:  J Buffington; S Damon; L Moyer; D Culver
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.

Authors:  C Mathei; Z Shkedy; B Denis; C Kabali; M Aerts; G Molenberghs; P Van Damme; F Buntinx
Journal:  J Viral Hepat       Date:  2006-08       Impact factor: 3.728

Review 3.  A framework for management of hepatitis C in prisons.

Authors:  Anne C Spaulding; Cindy M Weinbaum; Daryl T-Y Lau; Richard Sterling; Leonard B Seeff; Harold S Margolis; Jay H Hoofnagle
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

Review 4.  Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.

Authors:  John B Wong
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Description of a new hepatitis C risk assessment tool.

Authors:  Minhhuyen T Nguyen; Steven K Herrine; Christine A Laine; Karen Ruth; David S Weinberg
Journal:  Arch Intern Med       Date:  2005-09-26

6.  Human immunodeficiency virus and hepatitis testing and prevalence among surgical patients in an urban university hospital.

Authors:  Eric S Weiss; Edward E Cornwell; Theresa Wang; Dora Syin; E Anne Millman; Peter J Pronovost; David Chang; Martin A Makary
Journal:  Am J Surg       Date:  2007-01       Impact factor: 2.565

7.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

8.  Gaining and losing health insurance: strengthening the evidence for effects on access to care and health outcomes.

Authors:  J D Kasper; T A Giovannini; C Hoffman
Journal:  Med Care Res Rev       Date:  2000-09       Impact factor: 3.929

9.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

10.  Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems.

Authors:  Judith I Tsui; Mark J Pletcher; Eric Vittinghoff; Karen Seal; Ralph Gonzales
Journal:  J Hepatol       Date:  2005-08-24       Impact factor: 25.083

View more
  3 in total

1.  Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.

Authors:  Daniel John Smyth; Duncan Webster; Lisa Barrett; Mark MacMillan; Lisa McKnight; Frank Schweiger
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

2.  Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.

Authors:  Barbara S Taylor; Joshua T Hanson; Poornachand Veerapaneni; Roberto Villarreal; Kristin Fiebelkorn; Barbara J Turner
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

3.  [Prevalence of blood-borne pathogens among 275 trauma patients : A prospective observational study].

Authors:  S Wicker; H F Rabenau; B Scheller; I Marzi; S Wutzler
Journal:  Unfallchirurg       Date:  2016-08       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.